<SEC-DOCUMENT>0000950170-24-087284.txt : 20240729
<SEC-HEADER>0000950170-24-087284.hdr.sgml : 20240729
<ACCEPTANCE-DATETIME>20240729161046
ACCESSION NUMBER:		0000950170-24-087284
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20240723
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240729
DATE AS OF CHANGE:		20240729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Terns Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001831363
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39926
		FILM NUMBER:		241152452

	BUSINESS ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-525-5535 EXT.101

	MAIL ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tern-20240723.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-07-29T14:04:04.7602+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:tern="http://www.ternspharma.com/20240723" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_97ccfa0b-d768-4b91-bee4-979b8e08a603" name="dei:AmendmentFlag" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a">false</ix:nonNumeric><ix:nonNumeric id="F_361f66b1-15f6-492b-a5bc-3f70110c7acb" name="dei:EntityCentralIndexKey" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a">0001831363</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tern-20240723.xsd"/></ix:references><ix:resources><xbrli:context id="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831363</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-23</xbrli:startDate><xbrli:endDate>2024-07-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b32c5edc-a105-4dbe-9ad7-b01b64a2ce03" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_ff33d190-32aa-4165-8f72-e8154ccde736" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">July 23, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_65306afa-7ea1-4f4f-bd14-622efbccfb47" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Terns Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fbcbc70a-f276-41c3-b6f0-309af10d23cb" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_607d1fd8-91ee-4daf-9b6d-ea6781722ef5" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-39926</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_974014b4-f3dc-45aa-99df-079d4838c4e2" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">98-1448275</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_8186c800-ddb4-48c2-91ff-a2521c6603c2" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1065 East Hillsdale Blvd.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_df6bb857-d840-4773-a96f-fd79982dc8a4" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d8692bc5-59c4-4c1d-81a0-6a6d3f85ccd1" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Foster City</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_7799ffbe-d3d3-460b-b412-f5a180eda78d" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6eeb8cae-7942-4c9c-8605-06c11320d7fb" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">94404</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_15643b6d-5c3e-4a81-a157-e68a2e63ee24" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(650)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_94ddee29-1a02-4099-a477-31451f42b89a" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">525-5535</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d2039f3b-661d-4a55-a5b0-06b7a58137bc" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">N/A</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a08f983-44d1-478e-b6ab-fcde606ec632" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f39b2fba-61f1-4dc7-ae28-022167ea37a5" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a7d6977-0bda-4181-bcec-6927fcfd5d96" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_700df530-7a10-4d1f-ad84-2949f5483a64" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_96c46e72-74aa-4f5c-8e86-4840361b006a" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fc271282-a7f0-4960-bfce-ad0dc9dfa1b0" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">TERN</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fa8e8d1b-5a63-49a0-9da3-c973972a2984" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_37f525bb-7d30-4ecd-8242-f57871949091" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_8f4272f0-fb07-4810-b9fa-de9f6ccee1f0" contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Executive Leadership Transition</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Mark Vignola</span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 23, 2024, Terns Pharmaceuticals, Inc. (the &#8220;Company&#8221;), Terns, Inc., a wholly-owned subsidiary of the Company (the &#8220;Subsidiary&#8221;), and Mark Vignola, Ph.D., the Company&#8217;s Chief Financial Officer, entered into a letter agreement (the &#8220;Vignola Transition Agreement&#8221;) related to the anticipated transition, separation and resignation of Dr. Vignola and release of claims. The Vignola Transition Agreement provides for Dr. Vignola&#8217;s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the &#8220;Vignola Separation Date&#8221;), anticipated to be February 1, 2025.  Dr. Vignola has agreed to deliver such necessary resignations or written confirmations of changes in title and employment as the Company may request. During the period through the Vignola Separation Date, in addition to fulfilling his duties as Chief Financial Officer, Dr. Vignola will attend to the transition of his job duties in cooperation with the Company.</span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Vignola Transition Agreement, Dr. Vignola is entitled to receive severance in the amount of $475,000, equivalent to 12 months of his annual base salary, less applicable payroll withholdings, payable on a pro rata payroll basis following the Vignola Separation Date. The Vignola Transition Agreement also provides for the payment following the Vignola Separation Date of Dr. Vignola&#8217;s target annual bonus for 2024 and a pro rata portion of Dr. Vignola&#8217;s target annual bonus for 2025 based on the Vignola Separation Date, in each case with the target bonus being equivalent to 40% of Dr. Vignola&#8217;s annual base salary. In addition, subject to timely election by Dr. Vignola, the Vignola Transition Agreement provides for COBRA reimbursement by the Company as set forth in his Amended and Restated Employment Agreement, dated as of November 14, 2023 (the &#8220;Vignola Employment Agreement&#8221;), for up to 12 months following the Vignola Separation Date.  Further, the Vignola Transition Agreement provides that the time for Dr. Vignola to exercise any outstanding equity award that is vested as of the Vignola Separation Date shall continue to and include the end of the 12th month following the Vignola Separation Date.   The Company has agreed to pay up to $10,000 in attorney&#8217;s fees for Dr. Vignola in relation to the preparation of the Vignola Transition Agreement.  The foregoing payments and benefits are made subject to Dr. Vignola&#8217;s compliance with the Vignola Transition Agreement and the release of claims and applicable restrictive covenants therein and execution by Dr. Vignola of a supplemental release of claims as of the Vignola Separation Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dr. Vignola will also be entitled to receive the balance of his retention bonus as provided in the Vignola Employment Agreement, in the amount of $452,250, less applicable payroll withholdings, on the first payroll date after August 2, 2024.  In addition, under the Vignola Transition Agreement, the Company has agreed to pay Dr. Vignola an additional retention bonus in the amount of $500,000, provided Dr. Vignola remains employed until February 1, 2025, with such additional retention bonus being payable in a pro rata amount if Dr. Vignola resigns for Good Reason or is terminated without Cause pursuant to the Vignola Employment Agreement, or due to his death or disability, between the period from August 2, 2024 to February 1, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Vignola Transition Agreement contains customary non-disclosure and mutual non-disparagement obligations. The foregoing description of the Vignola Transition Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Transition Agreement.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Bryan Yoon</span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 23, 2024, the Company, the Subsidiary and Bryan Yoon entered into a letter agreement (the &#8220;Yoon Separation Agreement&#8221;) related to the anticipated transition, separation and resignation of Mr. Yoon and release of claims.  Effective upon the execution of the Yoon Separation Agreement, Mr. Yoon has assumed the title of Chief Operating Officer and Special Counsel and has ceased to serve as General Counsel and Secretary of the Company.  The Yoon Separation Agreement provides for Mr. Yoon&#8217;s continued service as Chief Operating Officer and Special Counsel for a transition period until September 3, 2024 (the &#8220;Yoon Separation Date&#8221;). Mr. Yoon&#8217;s employment will terminate and he will cease to hold any positions with the Company as of the Yoon Separation Date.  Mr. Yoon has agreed to deliver such resignations or written confirmations of changes in titles and employment as the Company may request.  During the period through the Yoon Separation Date, as Chief Operating Officer and Special Counsel, Mr. Yoon will attend to the transition of his job duties in cooperation with the Company.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Yoon Separation Agreement, Mr. Yoon is entitled to receive severance in the amount of $490,700, equivalent to 12 months of his annual base salary, less applicable payroll withholdings, payable on a pro rata payroll basis following the Yoon Separation Date.  Mr. Yoon will also be entitled to receive the balance of his retention bonus as provided in his Amended and Restated Employment Agreement, dated as of November 14, 2023 (the &#8220;Yoon Employment Agreement&#8221;), in the amount of $301,500, less applicable payroll withholdings, on the first payroll date after August 1, 2024.  The Yoon Separation Agreement also provides for the payment following the Yoon Separation Date of a pro rata portion of Mr. Yoon&#8217;s target annual bonus for 2024 (equivalent to 40% of Mr. Yoon&#8217;s annual base salary) based on the Yoon Separation Date. In addition, subject to timely election by Mr. Yoon, the Yoon Separation Agreement provides for COBRA reimbursement by the Company as set forth in the Yoon Employment Agreement for up to 12 months following the Yoon Separation Date.  Further, the Yoon Separation Agreement provides that the time for Mr. Yoon to exercise any outstanding equity award that is vested as of the Yoon Separation Date shall continue to and include April 30, 2025. The foregoing payments and benefits are made subject to Mr. Yoon&#8217;s compliance with the Yoon Separation Agreement and the release of claims and applicable restrictive covenants therein and execution by Mr. Yoon of a supplemental release of claims as of the Yoon Separation Date.  The Yoon Separation Agreement contains customary non-disclosure and mutual non-disparagement obligations.  The foregoing description of the Yoon Separation Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Yoon Separation Agreement.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 29, 2024, the Company issued a press release announcing the appointment of Elona Kogan as Chief Legal Officer, the anticipated transition and separation of Dr. Vignola and Mr. Yoon and a search for a new Chief Financial Officer. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;"/>
    <td style="width:1%;"/>
    <td style="width:90%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit<br/>No.</span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tern-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release issued by Terns Pharmaceuticals, Inc. on July 29, 2024.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">TERNS PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">July 29, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Amy Burroughs</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amy Burroughs<br/>Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tern-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img52906712_0.jpg" alt="img52906712_0.jpg" style="width:155px;height:81px;">&#160;</p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">FOSTER CITY, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (&#x201c;Terns&#x201d; or the &#x201c;Company&#x201d;) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Elona Kogan, Esq., as chief legal officer, effective immediately.  Ms. Kogan brings a wealth of industry experience and has successfully guided several biotechnology companies through transformational growth and transactions.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;Elona&#x2019;s proven leadership and deep industry knowledge make her an ideal addition to the Terns team,&#x201d; said Amy Burroughs, chief executive officer of Terns. &#x201c;As we advance our pipeline and execute on our strategic priorities, her expertise will be instrumental in driving our growth and success.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;I am thrilled to join Terns at this exciting time,&#x201d; said Ms. Kogan. &#x201c;The company&#x2019;s commitment to developing life-changing therapies aligns perfectly with my passion for the industry and working with a highly motivated and accomplished team.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Ms. Kogan joins Terns with a distinguished career spanning over 20 years in the life sciences sector. Previously, she served as chief legal officer at Seer, Inc., where she played a pivotal role in the company&#x2019;s IPO and commercialization. She has also held leadership positions at ARIAD Pharmaceuticals, Avanir Pharmaceuticals, and King Pharmaceuticals. Ms. Kogan&#x2019;s full biography can be viewed on the Terns website.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Bryan Yoon, Esq., chief operating officer, will remain with the company through September 3, 2024 as part of the transition.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In addition, the Company announces that Mark Vignola, Ph.D., chief financial officer, will leave in a planned transition following the appointment of a new chief financial officer. A search is underway, and Dr. Vignola will continue to serve as CFO through the end of January 2025, or until a successor is found.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;On behalf of the Terns&#x2019; team and Board, I thank Bryan and Mark for their many contributions to the Company&#x2019;s growth and development as they have both been integral to Terns&#x2019; success to date,&#x201d; said Ms. Burroughs. &#x201c;I want to express my personal appreciation to Mark and Bryan for their support throughout my transition as the new CEO during this period of tremendous opportunity at the company.  They leave Terns in strong hands with an experienced leadership team committed to advancing the important work they began.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:19.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;I am extremely proud of what we have accomplished at Terns. In recent months, it has been important to me to fully support the onboarding of our new leadership during this exciting time in the company&#x2019;s development,&#x201d; stated Dr. Vignola.  &#x201c;I believe now is the right time for me to help transition my successor and subsequently depart from Terns, confident the Company is in a strong position to continue to advance our pipeline with a committed, experienced team and CEO in place. I look forward to continuing to support this team and the company as we advance towards multiple important data readouts from our pipeline in the coming months.&#x201d;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">About Terns Pharmaceuticals</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns&#x2019; pipeline includes three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-&#x3b2; agonist, and a preclinical GIPR modulator program. For more information, please visit: </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.ternspharma.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This press release contains forward-looking statements about the Company within the meaning of the federal securities laws, including those related to expectations, timing and potential results of the clinical trials and other development activities of the Company and its partners; the potential indications to be targeted by the Company with its small-molecule product candidates; the therapeutic potential of the Company&#x2019;s small-molecule product candidates; the potential for the mechanisms of action of the Company&#x2019;s product candidates to be therapeutic targets for their targeted indications; the Company&#x2019;s expectations regarding the profile of its product candidates, including efficacy, tolerability, safety, metabolic stability and pharmacokinetic profile and potential differentiation as compared to other products or product candidates; the Company&#x2019;s plans and expectations around the addition of key personnel; and the Company&#x2019;s expectations with regard to its cash runway and sufficiency of its cash resources. All statements other than statements of historical facts contained in this press release, including statements regarding the Company&#x2019;s strategy, future financial condition, future operations, future trial results, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#x201c;aim,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;assume,&#x201d; &#x201c;believe,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;design,&#x201d; &#x201c;due,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;goal,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;objective,&#x201d; &#x201c;plan,&#x201d; &#x201c;positioned,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;seek,&#x201d; &#x201c;should,&#x201d; &#x201c;target,&#x201d; &#x201c;will,&#x201d; &#x201c;would&#x201d; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results and the implementation of the Company&#x2019;s plans to vary materially, including the risks associated with the initiation, cost, timing, progress, results and utility of the Company&#x2019;s current and future research and development activities and preclinical studies and clinical trials. These risks are not exhaustive. For a detailed discussion of the risk factors that could affect the Company&#x2019;s actual results, please refer to the risk factors identified in the Company&#x2019;s SEC reports, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2023. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Contacts for Terns</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Investors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Justin Ng</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">investors@ternspharma.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Media</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Jenna Urban</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Berry &amp; Company Public Relations</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">media@ternspharma.com</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img52906712_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img52906712_0.jpg
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MX9#_V@ , P$  A$#$0   ;_
M
M
M
M
M
M                          #I.77%'8ZB'6STL0-GIO.>[%L,TTDM_C4S
MY'SZ                         !YUNXU^?OSL\?*[+HRNTQ\KG=60
M(YYNL@[MM#![;:&&^STN'=O0 !=?%9U<S&)L
M !Y]N8Y7+=OFN)ED4]_.?6/IQY=ET979]&5V71E=ECY/9=&5V71E=ICY?88^
M7VG3D=GCY79=&5V?1E>N1J93"K&ZHY2^OX\RV!\3J[N)U]O=8^7(/6;GL<?+
MSS12GT_3R                          >)R2'5TW%YYC+853<S(Q/[]^
M  <'JR.=VXX $I:]MGG=7?$RQZ? X&/E^BPZPI^U#Z F?"++YO#L
M                  'B.]B]?MH4E$JRJ;Y^UT7W[>D #&<':9-G:L  6 TS
MZ+K^N;SI^>//.8W,;$Z3](S!@-J_3YR                            &
M&Y>!"&=UA#RR*=\IFE;]OFZ[]\N'PX=GD\>F'K\DA8  L IGT5!BVZ$G]2WH
MZ=53WQSNKO                               \TV6FBW-*X\&G%:1EW4
M>C'C;"1]A4^ !ZA'Y7852WH_WR&V'G.IWX
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M/0NR!IUV92UW\4G=IL>ENG)9M*VNQZ774Q6<QLS]7JU6!5&Q]![,L'TTC
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M#$"1Y#DF*=\1T.>32^@              !CV;K:&/8/Y\WJ^1??F9ZO>
M   "MOXF:0R.28J=^8T9N>$?'OGUA7QE_P!<LRX\"^/7/K&B;9X6>;G#/0CP
MSX['ZSX[4\1+2OH               8]FZVJ;T3Y&MZ\T^RP       /@?<^
M!\CDGP/L<8^A^3[GS.*<XX1S#KCM3Y'\.(<L^IQ3Y'W/F<X
M  &/9NMC//*MES6UR                                     #K>_%_
M+YVG1E@
M
M
M
M
M
M                        #__:  @! 0 !!0+_ !KKW)N:R7O/N+&.GOJW
M0AIYZE,HNET>=<KH3<>=49*U04:4>5\54RV-(SPS")CM:21X5K.[3>K*4PK^
MRD.1B&*I!GG)P1/^4,\NXEQ<@7'[/2[D50H^+/\ %V23)Y5B1\9JO_J^@1"
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MKO\ ;%K=ZLF6=O-6EJAAK9D7%^J*O_I.."*^%<-PK=%?F2G?$98!7#\)+3(
M&N9+04Y\-S=UN))=R(;3%<5(X<])<H*&^OXK>D:^Z),-QHC#4:.R.EIAAL6F
MFQZ ;!$$4_< JWFQV^:Z67:E9X,VG0DZ/PI@I[!X4[+=[E:C6M&I"-W.*/0@
MB2QI2)[+I8)89VN\ GB"S*6)(+^4$T&F K_2K@EF;8O" 'NHL-R<P'-4GX7:
M&O;KA&I++L=S4-6WFS:/QJ>(:(7*G?6FV$.IAR2CTOH['&3CR47F3B-MZ4\)
M8BMOO>C=N6B.+8N)0Y,R3(TO25ALUT "-HVWK/Q2%:(6.R6B&$<5IQ7EZ\F2
M2>[D2"\HXO@\4>9$_<-<A>:;>%($U4%T!<2O9G4K0D5.3OKKN%T<W%&U0UY]
M :),TDZ4,E:1%_%7OK<]N1V8V%U<DMQ.R1"E*I119)W6@DFC)\:8^-7KYG=^
M$Q\:O7S.[\)CXU>OF=WX3'QJ]?,[OPF/C5Z^9W?A,6VQVZ3=BGW68Q!B"[:W
M&FU?D&C;:&XIJ@#J7E[D2V;C>GMRIL/MS"1()R@5CC.QZD8DFDN(RN6/C5Z^
M9W?A,?&KU\SN_"8^-7KYG=^$Q\:O7S.[\)B7;-N/3W)4*'VY])<$XH(QQFH]
M1,B747$>3+N7*QW&3=AGVJ8_!EBU:W'6T?CFK;B XAHACJ3EQ\:O7S.[\)CX
MU>OF=WX3'QJ]?,[OPF!8.[SX*'DC\VT3181>9"*.W)(*]*IIZ5PU<;/<(=T@
M/?FY<"0U*8)4\8>(R1"AA7,>45Y>[)AORKPCT20]&>TVETAXK#A-.:2XF::A
MQ.B[<FOG*MS3;[\69%.(^L=TU;X[(FJ\9H'*":IXBD-?&3O),-^5>$>B2'HS
MVFTND/%8<)IS27$S34.)=SVXY*<BPIG87UEQBBFC_!:D4$"5=0\-Y,^ZY%O.
MXXO;VE43MMO%VYS6W$2O#?:A \,0_P"F)O'QJ]?,[OPF$C+?7[:140'+I;9D
M:.2JO(LD&WF6?9<4!\.&9D&3'F1) (Y'E17FY$=]M>0V7V2-MP%Z46GW_<_5
M\WS9SO4$44B)4$1%*D1+DB(B9JJKBU6E$1#BQ0[13W4MVKTLJ\Z+(<*G@[[8
M_P#\V^_[BV=]L7ZSVCSMON;<^K"?2MP[W<?U87Z5M_<WU]9[OYVYWK=SLL@B
MC&8>DK0ZX78+HPG*V^WF@/"*^3>1-;:^"HK;-Q6ASB0;I&1]M"T\1DT56Y$5
M]!4A&1%? FS2OC#W+]ZZNGGS^+;N2TE_:;>]J-@B469L4^I*@R*<K,EE5'I%
M:$F:)BV[BL[O%@W..+P<G$9<\21%?1*H,B(^)-FGOA[M^]=73SY_&X_K.OT5
M;^XYL/:DLX<Q&0+<5UCEHDQQD-BXS:X3PKK8>)@T-YP>LB$(BJ+KPJJM57-5
M7-55>=>ZRG%?F[8E/BEWLQ&I!PS5$<G6\272Q<&ASRH+M-)\RC#N4!\),&?&
M8F1)#>8/QI+8O,NCX#;-%^_KGZOF^;.=[ UAJC6RMTDU2H_V91[,"^YZ\L@R
MYQKWZ<=AE[373Q6P<TUY::T6E<?$(7R5C\C'Q"%\E8_([EX-^-'>)-Y7 4)U
MEMPD'T)MY=-3%5I5<?$(7R5C\C"&$*(!BM1(8[(D*IR*BH%47N;<^K"?2MPQ
MM)MT =;+T]J!P4,%IMB]*E1)%1:*F/B$+Y*Q^1CXA"^2L?D8^(0ODK'Y&%)B
M,PR2I12:9;;54Y:*H"F7<WU]9[OYVYC[0..PR_H_533QF@<TZOUDKIUHM*TQ
M\0A?)6/R,?$(7R5C\C#UNO%GA\0FB"+<HT9EBY6]Q4+0]$E ".)H-:Z%JV?N
MA7%XL4I4*39[G.MCQBBB+CD&2Y'5T$7/AN\/4/@7&[+$X1$S:;G;KA'KGP_3
M,>4TZV'0.NT:J<E25>=>Y?O75T\^?[GZJ7B1IV]N.0 QW'3HU:[V>EIF0JKD
M$>X(@LN\R$C99(A=V_>NKIY\_C<?UG7Z*M^''C\1ILW#IFND!4BHG/DF+G>9
MI*4NZSY=PD*I:O*RWS?-$5?<BIT3P8F[UW)!9N@,7 [;9;=,;%Z"AQVF795P
M?CGJ;EEJ?1MH332"@:T5=*B@C;X(B*(@BD1A$1$R1$1&Z(B)B8SZ-@PK^$<R
MM-YC1VH\EJ4V"K'9E.M")28+A)I,#JB"M1H5%P0&*B0JHD)(J$)(M%$D7-%1
M<,QWR(_05ZN5G9(LUX&B)=&QKRJ+?I32G0B4Y$^_KGZOF^;.=[)O#H4>O$G2
MRJIGV*"IM!3G'7)5RO2@I]SO/UTN/T'MSO-N?5A/I6X8VG(EOLQ8[?IW6_(=
M!ED-6VKR ZW'%$!U&2(GA7'Z?LOSI!^'Q^G[+\Z0?A\?I^R_.D'X?!-P;E F
MN .LPB3(\@Q"J)K(67#5!JO+W-]?6>[^=N8W]V^?"@\7]5N%VR4Q&XO#_6/7
MP^,8:]&M*TY*X_3]E^=(/P^/T_9?G2#\/A^?.OEOF24:(H=IMTR/+N,]VA<-
MMIE@W%:;,THKIT;#G7%VODRG:KQ<IMSD(/B"].D.23 .AL"<H*<R8W3?G!46
M;Q<X$&-J14X@V5B2;CH<RM\6ZJ%?? J<W<OWKJZ>?/XW5?+0T;NX-LW5EUJ,
MW4EN-K.#Q)L0 YY3.CBM4S*A!15-*8]!7B1KW/MUEMMPW"\K=+4E&HUPSS<?
M9R:D+FNK2:YN=R_>NKIY\_C<?UG7Z*M^'&7$J#H&V:<E1,5$DJF:9+BZV28)
M!*M5PEP'D(=-3BO&SK1%]RYIU(O(J+B;LW<\UNUQI4\KE:+I*+1!;>?::9E0
M9CZ]2&"]G%QMP_)U4T)1ZM4(=P60A)$5%2ZP%147-%14?S1<$4&;$FB.1%$D
MLR$%>@E9,T3\ 7/U?-\V<[R+!C#KD3)#,5@>EU]P6@3P)J+$&VQ_S$&*Q%;Z
M2%AL6]9?C'2J^'[G>?KI<?H/;G>;<^K"?2MP[W<?U87Z5M_<WU]9[OYVYWH0
MK3'-FW-.BEUO;S1=@MK7C%4NJC\P@_-L"NLUY=(U)+;MZT-<&WVN,,=A%HKC
MBYF[(?(4%#D2GB)QPJ)4R7N7[UU=//G\;N]=0?,5Q^L]HCZ-N[CD&3@-IY.V
M7HM3LB+1,@CS4176>9%UCD@CBV[CM)Z95O?0R:4E1J9&+J2H4BG*Q*9517HY
M4S1,6S<5H<XD*Y1T=$55.+'=3J2(CZ"JH,B*^*@:=*=&+]ZZNGGS^-Q_6=?H
MJW]P]\[2BE+NHL %^M# ZI%Q:C-HVQ<(+:)J>FLL C;C29N@(Z$U(J&0&) 8
M$HF!(HD)"M"$A7,2%>XW,@2Y,&6R6IF5#?=C2&B3D)MYD@< O87$/;/V@2NV
M0Y+@1X6Y7J#)ANEU6F[N2)23&<.@\=:&VJU<4AS'[^N?J^;YLYWAW-P*Q[+'
M5U%YNVRD)B,/1DUQ#\"BGW2\_72X_0>W.\VY]6$^E;AC;NWKXP<FUW#TMVIE
MM]V,9]DL=SFLT>8('0TR(PKDN=*8_04WY\N_][Q^@IOSY=_[WC]!3?GR[_WO
M$JX[9MS\.7,B=B?-VX39B%'XS;^E DO.B*\1I,TS[F^OK/=_.W,;P_6B"]-]
M$?J_V'@SI</A]O\ 3?:=7976N)K[$WRUI3'Z"F_/EW_O>);4*US(DQV,^W$E
MK=[H\D62;1"Q(5ER4K;O!=5"TJE%IB7;YC:LRX,E^'*9+QFI$9TF7VR\(. J
M8NNU7B3M&WI_:XH\E;;=U<=HGOE9N#;RDO-Q1[M^]=73SY_&[O74'S%<7/;M
MW;XD*Y1U:(D1.+'=3KQY;"DBH,B*^*&"]*=&+EMR[!IE6]]0%U!5&ID8NO%F
MQZ\K$IE4).CD7-%Q^K%WD:-N[CD +9N+Y.V7HM+4>55<@CS41&GN9%T%D@EB
M_>NKIY\_C<?UG7Z*M_=-^_[9@2IA^-<&.+;[B:TH*NS;>Y&D2-',CA&/@Q^@
MIOSY=_[WB=>=BO7!J=;F'9;EEF/=M9G1V1)QUN&\0C)9EBVBZ$(G$<IIR5:]
MRS/RW%>G6@WK!,=):DX5NX?9"->57%MKS&I5S(JKS_?US]7S?-G.\C/N!IDW
M@UN3M4ZW!<1 A#_)[,*'[)K]TO/UTN/T'MSO-N?5A/I6X8VA_P#?_P#Y>]=]
MOKZSW?SMS'VA?])_]S=UZZ,-:(&ZHP79M1&C:7!ND6Z-(M.LZ3P#(/PR,61U
MUSAP+T1;>N%<AX=S)L8ADO((M7-M@B7F!%[M^]=73SY_&[O74'S%>YZ?M,?7
MN7;C#CC8MA5VZ6E*NRK?U>LX^QFZPF?6U GYSN$9DI$2J1$2JI$2K52)5S55
M7&X_K.OT5;\."T?#=5LT;-4U(#BBN@U1:HNDL/1I&ZR:?CNN,/-%M_:^IMUH
ME!P"_P %\8#&F+G;]S70)NZ;;,)_./"AG)L[[;*,.ML0H\5DNS24,#H&2*%5
MZW<N>X+JZ+4*V17)!U)!)YP4\A%9KXTB4]1L$YR+!N:0#69'H;32V&I572 Y
MZ0&N2=&);SHT"X;JNDR,OOV0@6F I?*(+B>U]_7/U?-\V<[MLM#=?[;+;:<)
M.5N.GE)3O^QC 1>UAMEH4!IH!;; ?%!L!00%/ (I]TO/UTN/T'MSO-N?5A/I
M6X8BWNQS#M]TA<?LLML&G#:[3'=B/4!]MUI=<=\AS%>7'[93?D5H_P"7X_;*
M;\BM'_+\?ME-^16C_E^+Y!W-?G[K$BV%9;#+L>$TC<CTA"9XB+&C,$J\-Q4S
M6F?<WU]9[OYVYC[0O^D_^YNZ5W8;USMJ2PN0J@U-;=(TQ+FVG0 B3;Y>"/A"
M%5$A5%$D6BHJ9HJ*G(J8V[N'4A2)EO;;N%*)IN<-5AW'JIX@E+8(A_$5%[E^
M]=73SY_&[O74'S%>[^M%GC:=N;BD&3H-CY*UWH]3K\6B)1N/.H3K/,BZQ2B"
M/<W']9U^BK?W)6\;;')S;NXI2R)1M"JI:[S(ZTIJ12NEFX/5=;+DU$094'4Q
M<+9,E6^=&/7'F0GW8TED^34T\R0. M%YEP+8[SN"H.2*Y'MKQ_SG'8)N%[:X
M;+<E_N5W1DE-EF4^O963*NHV8C>B*R:HM*B"+3+DQ"V_9(ZOS)CE"-47@1(X
MYOS);G(U&CAFJ\_(E25$6S[;M^<6T0FXHN*FDGW,SDRG!15079<DS<+FU%]_
M7/U?-\V<[MSW Z/4AM);XBJG_$R*.R3'H)F.@C[#WW3]KK+\BG?QXG6&=<8M
MS=EWV3=A?B-.M-BV_;[9#1I1>ZVM"@*O10N\M=V@WN!;&X%I2W&U+CR'3</M
MDF3Q!5G)!H_3VL?M=9?D4[^/'[767Y%._CQ^UUE^13OX\?M=9?D4[^/%TNTZ
M]P+FW/M*VX&HD>0T;9]LC2>(2O9*-&*>WW-P;A8W/:8S-YNTVXMQW8DPG&0E
M/$Z+9D"Z2(47FQN7M]WA77T[Z&X78V7V>!Z,]*Z^)QO&XOI!*4][W9MMFM\:
M'<(DF#+:7D=C2V38?;7^6TXJ8+1NZSZ-2Z-4&;JTUZNJA4U4Q=+)=+Q"NT.3
M< N,#LC,AHHKKC",3@/CJODW. THH/(6KI[EQG!NNSMC-G2Y8@4.:I ,F0X\
M@DJ+15%#Q>H,^Z1+H5TG,2P.(R\R+0LQU9431[-55>[<MNWAKBP;G')D^3B,
MN>/'E,*M4&1$?$7 7WPX73N^S*-5TJL":*JG,JBAE1?;7%TM,ZY1;FY/NRW$
M'8C3K0-AV.-&X9(]FI58K[?<D0)\9B;"E-$S)BR6@>8?:/(FW6G$4#%<.2]K
MWN7MSBDIK;Y$;TO !5KU(I%)B3([?\MQZG^;]KK+\BG?QX$K[O(.SH778M-K
M7C.#T#+F2-#!?[%S!0-MVX8W&T+,G/%Q[C/,*Z2ERR36:#5=(#I:"JZ12J_?
M]S]7S?-G.[:X1CIDN,]MF>^[5,\L8'DG68!1;_F?N+N?J^;YLYW+7",=49M[
MMLSWO98?EC \EZKYH+?\_P#<9<_5\WS9SN7/<#H]>8ZEOB*J?\-'H[),>D7I
M"B/LL_>.Y-OPMW7.Q1($5)S7!5U]H1 +6TK(L)+B("$4Q2K7FY,\7K:%RO?Z
MQQ(D0Y#-P5>(0NME$\5W49Z:2M#@*1:'!HB\M;@NZ-SQDE^DJ1_3-VCM/]G[
M*Q^:26\)JUQ*\F5<;Z25<W[C$BW**EMUR%D,-1W95YIV5=1 C3C;0>+DJ(F+
MDNW9DIJV;4;AI<$CND,5R0LMH'5E BT=_M4A&%%>9M<7&_6MXV%?V^]/BNM'
M1V.X497$1#&BBZP>2]!)AO<+_P!JDFVNDQ->6WR7E7AK$D26 %QY;H#E'T80
MOS/NN1>>]W=^:^U=;?<8\%BY,_V>2ZSV^SKQ-;2 FO1,-I53QD'/.N-XG>9L
MB5<+1#;N<)V8\3CI!<H6F$V)E54:[0+:^#BXN<>[W2X3FV[0,AMJ9(<=$2.1
M%T.B)JM%)ISEZ%Q)M^VILR/'VW;1F7583I BFZ]'XIOZ<G&XXOM#1>15/ [K
MIJ9&T.W!YH%Y'HS)]IBHO2,ELFZX=W*[O*?80DNR!M<"W=I:B:&'2;ZXQY<:
MC0O K=51QQ:555Y%W">Y-<2[P&#]'W%F2PLIYC4&EQPHCA:'FUKUNJ1"J52M
M56'<)GVS):),D#)VW29K''BJ+KC:"YQ;[&<J0AJS <EQMQ;?N>5/D'/T.7V*
M^K97)AUB8^!:VI$A#;IIIY0D73AZ7;9<B#)2="!'XSA-.H!F6H=8T6A8M5\@
M[SN5F%G:T%R1#8:==29*;BN2W9;CPSXU'9'$05ZB^+7$>_/;ZN[+,:Z\)VW&
M+TD)+<18[Q@3ZW!G2,@7-*^36GAQ]HY7&=+DVRQ-SI;,5QTS:CLQ'WC)([:U
M$/)-TRQ)W$[N^=MV,Y(?9MD"V=H;8TM*E5-(\N)J: ^I4M;A*B^W)B;P;17X
MS^F#.X\=UV;&76BJ\C!EFVH]4B02(22J51<7&Z6B5,_5W;=RMUODQV72&&^J
M&[Q4D BZ'$F/QWA0O>Z<7.\6B6XR1P8<J%,CFK;B-R),51,"3,=;3G\.+%+F
M/N29+\$3>?>)3==/6?6,US)<6*QA>9.VK--C]HF7F(#RO:^.\T0(4<@?TQQ;
M!50"3\[4LL-^C]UM[UVH\S_;I3]R9?EP73![A^1=ER)C+H.@.7BD!\E4R_ %
MS]7S?-G,-LM"INNF+;8#XQN&2" IX2)<6RT-T_L41MIPDY')"^4E._[:29%[
M?WCNNW719(QV8230[*Z+3G&;&S,#4C;=31HDES8>6T13%^2@@]*D.D_)-L<T
M:0UH+;>K-4%$JO+R)2Y2;S;&IS[-TX#3ANR 46NRQW-%&7FT\<UQ]JTX0$(]
MHDQDC,U735N5?6(4;42JOE'5 /;Q<)L"=8F(6[4>*>-S1PILH4=D!Q5(;9*X
M-73,P431<]6-_;0N'5G;?B77AMJJY1W.,$EL/Q8\X26O^N3$#<%J9<_6$$GR
M'01QQP+DU%N<YE648<4@!\8[2:-")J4:*BJ5<7=EAB-"EVKT3$G0HK8,- :W
MJ 02FV0\5N9F7](AIS8VRS!51#>&T-I1W13Q'GVVK<R+:I[X7H+!^WX<;_?/
MJPK+9'*#5!56H10!::'\=S0@CX5Q>-P6R99(S.ZRG,3_ $H+INRF2=?&3PO\
M.F(W'-UTQR)%ZO@3&^/LSG&#=Q98N'8:D2M:G6^RO\,B$5[*KZM.#DBJ+JK@
M]M[DBW"%=+(],$(R1M:R4?D.RT!"U((.<5\LRH"A14):XW1<[Y!CP0=CN);>
M$V\V<B*A-KQW!=,ZAJ+2)(@ZM*K3DQ :O]K>?O MN=M=%J<2&?'=4**U*!O\
MRH\B8LMQVQ&>6SV^<A-L\)S7'@1AG6XW"$R-WAL2 1.?JK7DQ%L]G:G/76=+
MA.%#[*>I@F]2DUJ2J2'"<5$'AZJX2(^B(]%VYV9Y$6J(ZQ;.&XB+SHA#ASUS
M-_W$/'VLVT20"N,6Z01->0%EO2&$)>7(5<Q)VSNB+/@W&U299-M!&XO: >/C
M(V)(2"CBND6DE7A$%%0L;@W1=H4> VA*QMO0#H.R3DD;;+C@NF8OMQW'0ZXH
M*&C9X<8AS;"S:=QBU<'XT[C]N<_-N1C-WT6^K:^2$PHYE6O.N-T62749VW59
MBDV?YP8KMQ9-A"KSLNBXW3F0$Q9[9-=FI*A1!9?1N&;@(:$2]4T+K)GBP%>[
M##NFQ+U CSFYSD)\[C'=DL$X/#<[2(1W@$FR44%#5M5HN6+&7V>!<@@!UKJK
MO'[.,:I]J%%DZI"1R8R\JN;M-.=/P#<_5\WS9S$9]P-4:S@MR=JG5XS:H$(?
MY7:20_8!?O)7$;!'"R(T$4-4RR4J57D[E&VP;1<U0!$4KT]5$P2<!FCBU-.&
M'75,T4LNLJ*N$$4013)$1*(B="(G)@BX+6HT5#7AC4T7E0EIUD6F$$!$!3D$
M4012N>2)ERX)$89H=-:<(*%1:IJ2F=%P%6FUX5.'U!\G2E-&75I3FP2JRTJN
M>.JMA4^?K9=;-,(("(BG((H@HGL(F6.(C;:.+RN:!UK_ #J:L"<B+&?,/$-Y
MAIT@SKU2,54<\:2$2%<E%4115.BBY8^*Q_ZEO\G&@!$0]Z(H@YYKDF6>.,Q#
MBLNK6KK4=IMQ=7C=< 0L\47DQI; &QY: *"E>FB4P1BV F?C$(BA%_*5$JN!
M*1%CR"#Q">8;=4.?JJ8JHYXT&V!@G()")"E.3)4IEA$1*(F2(F2(B<R8/R#/
ME/'\F'7SKU\NMGCXK'_J6_R<<%QILV:(/",!)O2G(FA44:)A1C1V(XJM5%AH
M&D5>E4 115_ -S]7S?-G,'<W I(O4A747G[%%4F(P].;O$/PH2?N-E1D+1VB
M.^QKI73Q6R;U4RK35B+!C#HCPX[,5@>AIAL6@3PKI'_)[__:  @! 0,!/R'_
M ,UQY>B7@H%!ODHH&Y2XS-TYW$]Z+1' A7]@!W*/Y4S$,YZTJZZ4%+N;^"0H
M&+53(B39(8S%4B?B:9&O4DJ&*JR@1CZM#_ L8S&79 G=-$15-K=8N8\EZ+B(
MN)@@ U(K<N%V%E\T[ 1?3! I_C6L?"T>'DAC)*(5'\BSIXA*D;2(QRK8?8(1
M!2(3##%F<[)O(212S+'F4@,3'2YLT), ^JXS*?6^.AQI.$:U:#@?)9>(&:U0
M"_',8HD#H1N/&?.5S 5+!*CM5CA-U:)@F&*FCD9VA,9$FC$PD%K"1(:@>I92
M=C0UL)BEXL!Q3/NL6BR@0M@0;BRJM.))1@H,R%S0C5P1% ,+%E=A14\FW')B
MMJHV0$@=$X+QW4KYH3[4&T9-ZW@A:TQ!=-Y\5*;DDEE$;$0C(":FKP?8+E#<
M:D.=+BQ'\FEF!($ 6$$3&2B5\4230!@&U)<0V(&<4-LQ-XB",6=TX(6Q4QY)
M&CAR5 F)5HU0# NW69W2DD$4ND=BGRJ8I ,J!57A-ND^JR &MS& Q&$03%BH
M&T,V?.LH%XXNLCQDQLNL8 A'"A'!G^"3: ZS#F3,*CS5>"PD)8AEN7E3<30A
M!"2S.0XR\267R8?2:<';,\R+P9*@7K#EEL@ESY%Q/-19=86V!IH!]7&*@@(0
M"&5T& 4O(P(!J2SC<]BO*YP6G&+27HZ4>>81)R]@?<9].=L1OH3;C?N\(#[5
M+A5S(DX,B+7)328F+RDO*43VP6C ;>$"0.@"P?6XL< .$8 @&2<Z3$Y-:[$!
MT9UM?3PL&G9YKIMF!?B0A"@N47)=CP:6!\K+452H]!" .PMSF)Q$)$E!TKP=
M%YM"\)"&Q,T-T%8V(0G H3FPC%10Q>$N8=I8?X"$VA#$X/[:)3L_C-BRXQ7_
M '"EL@N,)W;*;V-2"YL$Y6)1<J!XL1$QT<2&&)S64$NI-(R)F2*B)YF+,E&1
MF),"X<P3&:2I21)!+?X81<0;9 IE'-C,D2!!!P5F9Z\RRD*WN=1,.-].9DR9
M,F3<!-WRT1E%N  ,,8Q!_"5^5DR9,D 8(QB#^$K\"X";OEHK +\C)DR5VD@K
M@<%D1D%Z*/+&F&39&BT \1^6PP8 !O#F4.KG2@/ T+#0N\1^6PP8 !O#F4D#
M!$,P?RE;BT@QD@H@)AB#4X,ET6,#"$LF4X4RZ+E^<&64OHCE!_P&(/*Z +K4
MC K>+%DNQB!E_:HJ'KU0"&":W!TB+E[2ZK;%*0[!AB0-"D/$I;4D3'BM6##8
M%P5F=;!*GA@E!H4A>4H]:;0<*3X4)'J!$RE!02HW5>)\()&'//P47!5FS+?*
M)6&,)A)O]#<[^LDQP%7=8&GG,)+0-4)&7@3'(1(AY;/ P)%6,)>!$M0KW"'A
M.9Q>Z*L*R*$DDLG(1(D;[#6FDH61,<5'Z+Q.S\QC!Q(D1N85E1*9MU$%M6(G
M4[8ZJ1F31R2"T$@WV18YR!2_DV XDY[#=%?>0H]GU%(0:Y#*I:"!,$%.0
M H'X XYR4T&E]0O($KH, ( PJ*=TMP!M358X4 ?,1"0.A&XUDSSRY/LKGP8L
M?0W-QP@ET2<KUA&]OZ'I[N98UNW 22!B\F3)DR<\::)'R1$O%1T/.)L-ZS.)
MQR9"HRQY85UWKF!A8S*P$KB'*(5B[]H,E=1SBPI:07P>>X7?03@4BE[S1]IQ
M G;!Q*/5H"HJ&2!%KE/S$TT3((BD)%$:%]04EH$B )Q1J1F#YTF0#(E(7O=#
M"'O]$<Y<PY&B<PY<BACNVD ""9>?FE_M^GKU0^QTE,!.]8B!@UU]K[((0ZP!
MJ"8Y"@')TFIHQ0ABP,E&WV(1L@X2:M(F$I=LJ2& F*3HJ%XE'N+QH@!,' ;T
M8>^3,X6A&$;CP!U)B](^R8@T2A)\NA>W*E$'Z'N6FZ^%:LM*U7GPW]#T]UNQ
M4A?Q<$)++R08,%NV'][J[> LC#BHZUP/6@SJ(EX02NI@36%F"MDAKU[/\.UY
MN5KK21U-6)A !C-Y"@&4NV5(3 3!(Q%(MON0C9)QDU:Q$,G2:FK-*&;!V4Y"
MCVYVDIFVOFA&(MP@AG?RM+/HAC#A,-<V&4I?TQDK/T(YO])D!/E!F>9?VUZ>
MRJ&QV#1Y!#,LL]B%I()Q* J*1)H*G*4 VQJ;63 D+,F$F12 /F(E)72K=>#T
MQ03H0!!081&*' 0H?_.$%N4%W<ML'NJS-6G M^\^DS4BY1%>:K7F[ $EJ-DT
MXD[4/H,G,;AO!10DDV'G46>_0"7D0&Q_1]/=>.9)?1_8$R&'D*E2HQLE=PET
MY-">90V.Z+7V\DT]3^0)+K&*"1,*5Y<+)+,P*L+AR<Q0"Z8HEDI# L 89XO7
MLFQ*<^+^*XEHB[+F1288)%,* "<AA*W:WQ1JVR+R:.8*VA H[<@"V$&4NNH.
MCI^1.QX4(S&"Q;Z"YN@S'!%A,[I$_E2*Z+HJ^*4TP&CR#&T)B41%H-YY21(D
M2+&T)B43-H%YX+;A!;@,M6QK[I@HJ^#I3B<0VKB1(XN'F%7OKT2^LL<V+31G
M=&",")QX26_#;27] &!"EI*1)7X (5TB6CB5F-9!('I@A I$D2F N%6Q!C$(
M-6D#Z%Q*)FTBT< @Y;-0!GDE02-:6)N!,,B((.!)+XMHV]TLO=(TIJ?81T'R
M;"9C,^@N</V%(L/B 48X_P"-<X?L*38?, HPQ_QSFR#$<16$QLD3^B2J%;F7
MMV>'< LY+4:B"3A^#5)2*L2%+K.\8N=1X&#&<.%U:&BF@_\ 8@'""FAB6IY:
M&WQ!"Q0II"'KHL4@1D@0LT:(#\'.V.'ZHTS1\:,"3,\E:4T<IGN4K#HIPU L
M2)?NN\5G-@HH@FVD(DG"EG'W*REP-*FL$(1H3 $!P+ 8U$9L>)S03#!/=FF7
M%Y^;,0$"- !,N@$HD7,Z@0C;#,I/JD9.!'#7W9\%1,*^BD)SM7N4VD,*;)C4
M1[I4,\:@!03!_$PT0';D\!5(*>ON42*V[:8+K#E?&ANT*<1;5 J*T,6@.&-M
MY31X3D!0+<22P+^.#/3=?0KD6>_2"7F0&[4[@M!!0DL6'E_1M?GHL8R7 @S%
MZ.<"8B *)B^-E0>**PMXK)$HMZ1H1YA^@(E5:2OG!YVD3" "&&E0GZJ )05E
MLFP4;C9U-E77VU@6KZJ@/Q?UCN!#8/6BM;P%_-68,:#-PEKHN10F:@[>!>L,
M;RI<+TP*D)P#293M291J.X D-R ,PK9JD3 .X04AJD?JBK0"SA1^M0!7UD55
MW:!:P^OP"&& [!E3!((ZQH(V1PY\#N7/9LOA7!LTTA[F&!2 "(UI3<I&\XAE
M<$6FC+?VCD)R)5DFAD9H\+UNV/;2Y>B@< (#>C=F>3R-S8+90(/@<OPP-2_F
M.(^A.;_28%3Y1(GF?])#NC0HCA6XN7!XZ)&H1( L%6;0+:4@VH$6;M'Q$''8
M0 "I7)@G:Q; 2,X5-G*Y@5#!*GO0!NT1P:HXTG!ID4H&ONO)(LB*$0$, D@V
M8@;S<K/J.9,L(%VAG"D!:"YDL:T/TP (A"\7V<:>$+<X!*.$X '2!%)@($E6
MG0:(<*0HAXWO2 0%"(DB-D1LB5<[#=.B8(EBKN*+ZLV2[K4UZ2:I%?X)M1Z%
M##@B#A#"@3"  ! !8 KI#?E6\WX3E;<QO@%<D6(BK)1V?Q8P9_0G)3=? %66
MA:KQY;_&(*(Q0LY%@O1)-9\PY6B<@Y<W_P ]_P#_V@ ( 0(# 3\A_P#-=Z!7
M:]:3>'_?:LO>'W8^*PPO=_$4'"?$GWIQ).['PTB,./U8@#R##UEZ8E)0S;)\
M450!K(X]%M2:1G9_C7&'9^TUBW]P]Y:NWE2^\5$B#9',9&<Q]C]O3ZM/2'<]
MH\XF258!J+=V^"S=4T17$& :!PXW'XK&EW7[5>']Z"LOC/X*0EE[1\4HS6EJ
MR8L=.M 0!=OR&B+=M]]4S!]U?93&Q-Q_8IJ;,QZ-U?HIVIX1(1W*&BJ+U] ,
M8S;'=K$5E%[)_=2/HO<5+L<O^A6%=I]Q*RVFOYC6-/I*\"KXP^JJB^Z^.?D*
MCKSE\&&@F54S_ I.:&A*(R,7J_.V#6%LS<-\R7D,'NU)A\WJU:*/K7NL/ =Z
M1JIBK+Z_5VH?RO1EZ*@1=3I3R)O0)*S&3VK!7FP_/GP,# R/@TAP05"Z(L;]
MK[F-U8T/3%W_  .ZE5B+ZWVE*X]S!\U&CZ@,5(X'O+WL^%H69HP' \HJ6;KS
MXU"$Y,/J 4[4TQ2)!_UT"[E4MM*N[WND[*E;$NJ5\O\ @,)W2?DGV58]H2_N
M>RK?O0A\FC[0,GI!H,H997YH98$>L66>Q5Q)<8627%9U ;M)M<HPV, ^7-?\
M-,:/PN:5"QZ[/H_,YFTCW5L>JMCU5L>JMCU5L>JCCA3CP;QP8QK8]5;'JK8]
M5;'JHO')C'@<<*<:V/56QZJV/50$P>R5 MW>(0$$UHL$EI?D" @FM$X9$\0Y
M>]L>_P!JV/50'LDI&!!_?Z;HY5!@"F9QGA^R.;V?W<WO7QPZ+8Y>BV>'M7QR
MPIV.9UI6+A</:OBL:I[;UCH7'VKXKHMWA#*<C[OVY-.'!^SM\4XMAA_O=-T<
MMR8_+'CUHYQ3"M]K?>!(G+1OM;SPZ+8IHATA6^UOM;[2F+P]J^*:65;[6^U-
M=VR:#!0/K1@XH>G[X>U?'"V%GU/^8^O'VKXKHMV@EBL)(B@BX)4Q[5OM#63*
MYUGP&4RG[?;^]TW1RRBS_C7T]Q_C]EY#HMBD$)?P5^N:_7-?KFKBP=N'M7Q5
MG5V4_7-?KFI]3,I 5A% >E&!BCZ_KA[5\47V4F;<+9?;=/Q_SA[5\5T6[0PS
M6$431XX"$S[FM?KFL'I] Z;HY%CA?8$M8UL?*8\8'\?LO(=%L<O1;/#VKXY9
M@;<S_P WK&HN'M7Q7O'S5VK/J?\ ,&L8)[;UBX%>U?%=%N\")HS--G;B#".Z
MI8H&.KM^/3^_TW1R1[X'K,X=E_D]EY#HMBK+HCX%;/T?BMGZ/Q6S]'XHB\AG
M .'M7Q5P(Q+#A_U6S]'XH(09:% 6,)J*,#[G_(X^U?%>\?-8N!6,$]MJLU9]
M3_F)7M7Q71;O$F%-&)Z-;/T?B@L<V)+1WVX$#1//_9_O=-T<DFY&/<O\W@_D
M]EY#HMBN@V<WM7QR%<6-'C+\>*B!I/'_ ">/M7Q7O'SPOA]MU_/_ #CT6[1C
M?"@$ECT8U%F#=OYX8T!18B@ ,@>Z_?\ O=-T<<[63? /*#S2=I15U7'^3V7D
M.BV*9'*RK;^K^:V_J_FMOZOYJ8.;]'A[5\<A7AA1YR_'GAH,-NS<]N'M7Q7O
M'SQNQ;]3_F?#HMW@;>SZG_,*CF+R:5O'W_-83]-:2K9[[5B)G][INCC,[[9!
MYD_R?WA1L4$?=?OR.R3+VK]X5^\*_>%?O"G9(E[<&TR!E5VUW'>/QQ,X1FM;
MU"GJ 0_;@+PAJ4O:#/CCH5?N"F9 A[\ 3P*ARWX/X^*_>%6<_=_'YJ0\Z&1V
M_O\ 3='&34GV:)W3Y?XOINCA)J'[-$[)\/\ &=-T<)G?;(/$G_&>FZ*3M *N
M@8UG:R;8!X >/H9])Z;HJ3<+'LW^;P?XWINBH]\#UF4.X_XVTLVSLS2QRON*
M7_SW_]H " $# P$_(?\ S7[J08KXW%]\/>L(SNH]B?FL/CHS4_(G<'Y*-&V<
M/)EW/2A!B+ZLZX(@+Q!C1P<FHL@W'V0T)(*L/ATN])2*V?QVU+H2Q7N6'V ^
M:LB/3[ GWH7#W3S3"X$_?]QY^K2\H6;=EN:Q=9&IDH7@+&Y]][C%2HD#>>,\
MTU%-]B"^]9CVA4L9&PU*L.Z?*U#D&\O=)H)!&40]95@94G#\ J8(-'\0TG/=
MOL"@8WL- 2\=A^]"+%E?:?LAJ<G1 !S$LE6GICB++;$PP7;9$-3@N6^@[U!]
MD_-=$"W/BHX7@^G-RKW5/LC66VB][M83.L([I#:6^7U4],G_ &,O$[16#*S-
MIOBH1*DI$Q_@B#SZ<RV4:'"V!H3;9JI?HHO(? <<C1O92P[K!]@5'G88@\<?
M)-E'B/ " [!]7+4^BS]@5$AT"/@1:/07$"/HT]9S>BQSX-FN9^21VX+V5)@+
M%AW?=<A@-86_4]+YICC"@ 0/K?;(28[.)XBI1'6#@I/MAL?:SR%+PC:L$< >
M/5A8!SX3&-1/JA%NU@40&7OL&:V,VA\V9[>S?LB;%&7F  #8+?X /NY(]&/=
M4UHZQT&ZD79WV4:5O($/K%[T<-*LD<T<)Z(^(0W2HY) XQ>2!&F*@PGD: ^K
MW>V!D#_#0$'\GFA?=>(CUF$[',8I1.()PK>JWJMZK>JWJG"FP=W L\";$UO5
M;U6]5O5-G@3<C@X4V'LK>JWJMZJ;.\7VFHN$S&>+-HF*-"Z21R,VB8HVGDBY
M'%V!L+OMAYK>JO(6Q/?\T<87F7/[_2M?*"-6P!G1GP??</6QMS>]YCJVO#K=
MW+UNSAU;7EFGNR=,G*L.(Z/&'#K6M8]1ZF9YI8I#H[G'K6M=;LX2AB-K$G)]
M_P!\A:ZI_P"AO\YT&:2D[/\ >Z5KY;:3V/#'RK,R>=P :VGI6T].#V!OIVGI
M4%P)[<.MW4!)PI;3TK:>E;3THP@.'5M:M -.T]*VGI2D,Y(7.ST5B&H]&*0.
M"?=P=:UX7RO=&S@^./6M:ZW92PEPK%1SZT5($ X;L9Z%?K*8E@L%YWU*PLT3
MS'X?WCI6OEA?A_+'KYX7\?N?(];NID0HOUJOUJOUJFH0V1X=6UJV"6=BOZU7
MZU2M#($5ZUPK&/SZLTKL"#U<'6M:;8SUA<[YGIGPNA8_ _9]<^'6M:ZW9220
MX5C'H]*2J228;CIKZU^E5A ]F?H'2M?('$F6X#W:P9:=A$N[B[_Q^Y\CUN[E
MZW9PZMKRP:@]@_[H474!'6[PZUK7LOQ5D+WIF/.)YK%JO4S/-865T>*ZUK76
M[.$>IAW(S-]L\M\+./">2.99HQ678SGW&_K_ '^E:^2,<^\ ^GF'\GN?(];N
MHPYO,L$_)6XZ-ZW'1O6XZ-Z<(&1BOSPZMK5U6#NF-V':MQT;T]CD;. ^M.;+
M0]RIWS!V_P"I]>/6M:]E^*PLKI\5BU7J9/FKH7O3(^<'Q76M:ZW9Q5DM>#ZD
M/K6XZ-Z>L!,KSVSGUX75;OQA[1_>Z5KY(KPOF6':)Y/Y/<^1ZW=S[=6UY%GL
M)]6'Y>:E[J_.'O''K6M>R_'"VEC\A]STSX8W:ZW93,6QI)8JT@!;$^$8/VX8
M*-/_ #S2RS2E<%'H/D_O=*U\<0 EMC\3X*-@& ,@L'@_D]SY'K=U 7R3W(^*
MWGI^%;ST_"MYZ?A3J#EEJ:'#JVO(NJC/AL_9\<-?5W<L^_#K6M>R_'&R%[_A
MYQ//#K=G!Z=Z7W/7$]*!JAF6:!(]H_%95.N'IA0@R_;=VK#NX_+Y;_WNE:^,
M*?O#3>$[?R/TK00$JSL'VY#XD-YU6OTK7Z5K]*U^E:/B0VG4>!T8[@YU8+I-
MO^N-Q,D>S3D0]FDCN1&6OVX&2-'!SHW"DMQ&*0Z>Y7Z%H^"EMV#@] 7B-3J[
M$AXN/S7Z5I>D.Z_:K.$XN;W>C^_TK7QB;&]L8/9'^+NE:^$39VMC![H_QETK
M7PA3]X:;0G?_ !CI6NC81@#-;!Y:P "6^/S/D_QG2M=17D?$L.\SR?XWI6NH
MQQ[P#Z^(?XV*F&0T@DT'$&6P#V/_ #W_ /_:  P# 0 "$0,1   0
M
M
M
M
M
M                                                       #>'
M                         "BS     _NMMN
M    'YM_(?J%:*J")[@                          =]MMM%MMYMI.
M                        %5=MMUMMLJ#H
M    % ,N5MMJ'                                *EMMM90
M                          =MM@  .VVX.VQ'VVH!0 . 66
M     -ML8  MMMPUMN&MM=%4 I#-N               -MI   K=# W;>&;9
MJ%J I3NL0              -MH    %0 QDD&$DD%% IP[
M  -M4    %0 UMN&MMK%Q.I'U7               -M     %0 S;;&+00%V
M)I K58              -M(    %0 Q  &8%(%PEA0X3P              -
ML     %0 S '&8&$%P$I%,T(              -L     '( O_\ 0J , "!&
MQ?[0              #;@                                    #6
M                                    #2       !(%$@(, !@(-$@@
M               #2       !,   H@(I,)(I)                #
M     )  ) (! !!((                #P
M            +P
M
M
M
M
M
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M;P+1-,%]6)%2"(R4# ;3Q(A$P$/T1!)?='$VLD M(MBF  M34*DE"KQ57^W
MKU\9P*:.7K'CD%2XZT>$[4ER;(#C[=P-J^P>"_ZA3JH"258L@I9RFM[ZGQ+[
M/.#D-[KWJ-.I.[0;HZJ]93SX @G@D03@&HW P&=$/)9HN<G;4DT!3/H9G0*D
M&G(S9TD9!!Q_HH%?OD_M+Q]G4A'C @0$2R(@>$U>BE)'ACZA)&C#R %0&*=Q
M X4W-9Y"B[SO!?66_=J2GZKY,J6L&A>9]N_J?$OL\X.0P"258D I91K>D;5]
M@\$_U*G7+]U[A CAI^R$P@,A5 (8O-V]"%G?![2,6D\^1Q(03Z$@6]/, @_
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M3Y^B'IMB[1C=X&#.O&] *0;2@R /ZQ"JKINCE>F66FY]M2L;L"O<R'0T#8(
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tern-20240723.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-07-29T14:04:05.1389+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.ternspharma.com/20240723" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:tern="http://www.ternspharma.com/20240723" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tern-20240723.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139901217338016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 23,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Terns Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1448275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1065 East Hillsdale Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">525-5535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TERN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !6@?U8.JJBYT !   \ @  #P
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M<F]P<R]A<' N>&UL4$L! A0#%     @ 5H']6*$5!4;O    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 5H']
M6)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !6@?U8RNC7?[H$  "/$@  &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 5H']
M6)^@&_"Q @  X@P   T              ( !_@P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !6@?U8EXJ[',     3 @  "P              @ ':#P
M7W)E;',O+G)E;'-02P$"% ,4    " !6@?U8.JJBYT !   \ @  #P
M        @ '#$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 5H']6"0>
MFZ*M    ^ $  !H              ( !,!(  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ 5H']6&60>9(9 0  SP,  !,
M     ( !%1,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&7Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tern-20240723.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tern-20240723.htm">tern-20240723.htm</File>
    <File>tern-20240723.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tern-20240723.htm": {
   "nsprefix": "tern",
   "nsuri": "http://www.ternspharma.com/20240723",
   "dts": {
    "inline": {
     "local": [
      "tern-20240723.htm"
     ]
    },
    "schema": {
     "local": [
      "tern-20240723.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20240723.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20240723.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ternspharma.com/20240723/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-24-087284-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-087284-xbrl.zip
M4$L#!!0    ( %:!_5C.'S8*.!H  $G'   1    =&5R;BTR,#(T,#<R,RYH
M=&WM7>ESVT:6_SY_18\RD\BU;!+W0=F>DB79T<2679*RD]TO4PUT0\0$!!@
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MUX)LO!;D1?C':=1^%=>P"5[O*BU[S_#ZAZSA#A"*G0' LL/+T=]9INB*VD)
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M+7[^Z>+X^M?+LZO=YL:S9'BZ!'EZC04N=P+Y'!^#L1)F..?T(8[NU\<E\+Q
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M[($;5QM53,Q4J,W'.*%I^=7GF-?LCQ_GA*VS!F/'I8;I"B2?6K^3OZXV0VK
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M:N:[-L(3B6_D",X$WP]R]C]02P,$%     @ 5H']6$./^3<&#P  PTD   \
M  !T97)N+65X.3E?,2YH=&WM7%UWVS82?=]?@6U/O\Z1%#MITD;R]JSC.EVW
M:9+C9+?;IST0"4J(08 %0,OJK]\[ Y*B+#IM=^WFRWF)!9# 8#!SY\X TL$R
MEN:;OXB#I9(Y_A<'44>COCG^]_CAP\G^P9WT$0_<:9XXF+M\+4)<&_6WCTKI
M%]I.A:RC^ZLN*^>CM'%6R3S7=C$57U<7LX]XV%R?MR\UO>/HJNG>Y+ZVLU+;
M\5+IQ3(V#7-W,0[Z5QIC[GRN_!@M&.F@:@<IG(WTB)KN[U5QE@1)0\ZXKY"E
M-NOI2UVJ()ZJE3AUI;3M@W,7HROQ;%07<2R-7MBI)P%H$GJ_G2=SQOGIQWO\
M;[9:ZJC&H9*9FE9>C5=>5FFZ51)_[DP^Z\FV#]GZXGQVA+GF7G\V"M*&<5!>
M%[S\E<[C<EKH.,[PN+(DR/'%4L]U%&DG:)AO#NY4-ZL$HPK6@2X7(OCL;Q_A
MC_MW'^X]^&K_[G_V)J^JQ4="FCC8WDB5EK)__SXVO]G5K_?9$#[]>/_!WHS7
M< <&P891;=O2F 28/I@\>/#5)[/K6=_7>+6WP@S*5?Z:]_G+_V>?7RIO@WB^
ME+[$A'74F31!'%:5TS8&\4B[J+*E.+Y0&3K/E3@VSDKQ@UM(*V001TNM"O%$
M+:01SXI"9\H+:7-Q:*VK;0;5_+/*'&9?B*/'S\1+#Y%TU,[VC&IK*V[0KOHZ
MOUK+U^ \K:V]T17^7JNZAO4^?O;BY?&I.#IY^?-(T(O%9"2^K\U:W'TX$G?W
M[GXI/O_NR;-'Q^+I\4\O?CHY/?Y"C,=BT/9&XL1F$_'YIQ]?W-W;SV;\4/J0
MSX3S(BZ5:#N/7%E)NVZ[OQ"?/Y4AE[],!>1Y^L5(2)$9;6G@<8ARH<1<NVIK
M0I&E,42NSI5Q%5FJ%!1-"F>T$ZX0H93&C$MGX -&B<J[O,ZBR&#G.I<1FQ2=
M0&#Q*@1!FG)U$+D.2@:%]6B;F9JBCG"6-F6Q9@]Q<P5/6(_P<BZI*3E,S@N4
MR0%+Z)<DZ#G=2!R'7Z!>^%[&OF?8]USRO9%01:$R]E1=EBK7D,^L)T+\&":-
MUV)7[2)@D2L%-%W2^-KF=8A^+=1%!?D5Y& 9EY@EU!G<.!2UP7XN:IU#Q !=
M><PZ3_!@TZJ2)C7I8^E=O5B*2.Y>.*B;7!XO++Q;84H:F_MD1AUA<HL&[P\:
MM,[)1IL^/)P%<IMS96&N$IPJ+'7%5I K56W,[\RZE5$Y_+249THL.9@(F!Q,
MAY@;&0LY&[E(0H^H9#GJX"%(C=!3KL6CVK,%POV2EZ@N@#6>0F;/0TPZ-#D,
M< G,<R[)_EWM1:4K!?Q(SI"&0(?E/@@,WUKH#"O3SD,V<G82F9THPO_%2ALX
M"5S1XNF:O!D+T5;D7I\S(&"<GDLTKC9IU_/AV(SX<);:6MN)D"4!)4R$0-^)
M5T#\QJIE1(\.L*0,=@5#B5C>)3/O 'UCP"_A%ED_))+?H:'4*9)@DEZ40YA6
MXVPI[8)G@.7*BL";M01_59XB"4!_I6&?<*I*AD .6#11N'-;LMV5\V<T#C\L
MQ1)4%:^6#CX'-\GY&9F1=$:'):T8GGMKZ>_S4C>4@TP[-+;=& CX$5EVG8PA
MDUX!.2&(M0R,X!<@CF*MI ^$F&1O9+ B9$Q/B&AET?F)>.[5.3$N RJ%L8B
MG9.]#?(C\JP7BG@2L<R16,'J%;]6&;FFUX#YYXY@VH/OM3/O.-7)\V=LT>1<
MRF<:6OF5.<Y$O,#SQ)O 91W"@<G[(:]R*?MA%S\\/3G\=I?_'B+^:+_;3O/]
M0,JYU#/90,%&0*)K1,\6V-#EFK@JQ:%SK598I+.]"+I2<\BD.@KV@?K%+06\
MQO4^\FL8W,_.=>E*\D6'H"(YH'7Y"E,DKTH)5V-HZ/E;ET>\4%54Y1S^>Z_)
M)^%@E?2<'-$+L:LKW*82[Y$=G=B.]H]XGYN$O\N6*=4$DOXH_9GX%P1V1HZ
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M^J_#KY6U4OS3S^6;_G+SGWG36WFD#)_*LIIUS.\YTSHP3)/2M@]'&_R%V]_
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M,#(T,#<R,RYH=&U02P$"% ,4    " !6@?U8E9F1$_T(  !E:0  $0
M        @ %G&@  =&5R;BTR,#(T,#<R,RYX<V102P$"% ,4    " !6@?U8
M0X_Y-P8/  ##20  #P              @ &3(P  =&5R;BUE>#DY7S$N:'1M
64$L%!@     #  , NP   ,8R      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tern-20240723_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tern-20240723.xsd" xlink:type="simple"/>
    <context id="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831363</identifier>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_97ccfa0b-d768-4b91-bee4-979b8e08a603">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_361f66b1-15f6-492b-a5bc-3f70110c7acb">0001831363</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_b32c5edc-a105-4dbe-9ad7-b01b64a2ce03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_ff33d190-32aa-4165-8f72-e8154ccde736">2024-07-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_65306afa-7ea1-4f4f-bd14-622efbccfb47">Terns Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_fbcbc70a-f276-41c3-b6f0-309af10d23cb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_607d1fd8-91ee-4daf-9b6d-ea6781722ef5">001-39926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_974014b4-f3dc-45aa-99df-079d4838c4e2">98-1448275</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_8186c800-ddb4-48c2-91ff-a2521c6603c2">1065 East Hillsdale Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_df6bb857-d840-4773-a96f-fd79982dc8a4">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_d8692bc5-59c4-4c1d-81a0-6a6d3f85ccd1">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_7799ffbe-d3d3-460b-b412-f5a180eda78d">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_6eeb8cae-7942-4c9c-8605-06c11320d7fb">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_15643b6d-5c3e-4a81-a157-e68a2e63ee24">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_94ddee29-1a02-4099-a477-31451f42b89a">525-5535</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_d2039f3b-661d-4a55-a5b0-06b7a58137bc">N/A</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_9a08f983-44d1-478e-b6ab-fcde606ec632">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_f39b2fba-61f1-4dc7-ae28-022167ea37a5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_2a7d6977-0bda-4181-bcec-6927fcfd5d96">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_700df530-7a10-4d1f-ad84-2949f5483a64">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_96c46e72-74aa-4f5c-8e86-4840361b006a">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_fc271282-a7f0-4960-bfce-ad0dc9dfa1b0">TERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_fa8e8d1b-5a63-49a0-9da3-c973972a2984">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_37f525bb-7d30-4ecd-8242-f57871949091">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_571b8d57-3a67-4eb5-8ab2-bc06bb726b0a"
      id="F_8f4272f0-fb07-4810-b9fa-de9f6ccee1f0">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
